Researchers for the past year have been studying a group of potent HIV-neutralizing antibodies. Now biologists have discovered a way to deliver the antibodies to mice.
The breakthrough by scientists at the California Institute of Technology (Caltech) has effectively protected the mice from HIV infection.
This new approach to HIV prevention—called Vectored ImmunoProphylaxis, or VIP—is outlined in the journal Nature.
Click "source" for entire article.